FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Error on the MGUS-Autoimmune Disease Association.

2.

Scientists develop scans that light up aggressive cancer tumors for better treatment

3.

Chemo causes lasting physical decline in breast cancer survivors

4.

How Do Younger People Fare With Stool Tests for CRC Screening?

5.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot